On September 3, 2019 Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, reported that Arnon Rosenthal, Ph.D., chief executive officer of Alector will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 10, at 12:55 p.m. ET in New York City (Press release, Alector, SEP 3, 2019, View Source [SID1234551116]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the audio portion of the fireside chat, please visit the "Events & Presentations" page within the Investors section of the Alector website at View Source A replay will be available on the Alector website for 90 days following the conference.